Gainers
- Allakos Inc. ALLK shares jumped 109% to $64.80 after the company's AK002 met all primary and secondary endpoints in its Phase 2 study. The company also reported better-than-expected Q2 EPS results.
- KURA SUSHI USA, INC. KRUS shares rose 24.4% to $24.40 after climbing 24.43% on Friday.
- Sandstorm Gold Ltd. SAND gained 10.7% to $6.86.
- Endeavour Silver Corp. EXK rose 10.6% to $2.6101 amid heightened US-China trade tensions. Concerns of a looming trade war have driven up the demand for 'safe-haven' assets such as metals.
- Golden Star Resources Ltd. GSS shares rose 9.4% to $3.61.
- Fortuna Silver Mines Inc. FSM shares surged 9% to $4.3050.
- Coeur Mining, Inc. CDE rose 8.6% to $5.19.
- Osisko Gold Royalties Ltd OR shares gained 8.4% to $13.10 amid heightened US-China trade tensions. Concerns of a trade war have led investors into 'safe-haven' assets such as gold.
- Tyson Foods, Inc. TSN shares gained 8% to $86.41 after reporting better-than-expected earnings for its third quarter.
- Boise Cascade Company BCC gained 7.8% to $29.39 after the company posted upbeat Q2 earnings.
- Kirkland Lake Gold Ltd. KL climbed 7.8% to $47.50.
- First Majestic Silver Corp. AG rose 7.8% to $10.29.
- IAMGOLD Corporation IAG shares climbed 7.8% to $4.02.
- Americas Silver Corporation USAS shares gained 7.7% to $3.0701.
- B2Gold Corp. BTG climbed 7.2% to $3.5150.
- Alamos Gold Inc. AGI rose 7.1% to $7.59.
- Glu Mobile Inc. GLUU gained 5.7% to $5.10 following a positive Seeking Alpha contributor post calling the stock's recent sell off into the $4s "completely irrational."
- Harmony Gold Mining Company Limited HMY rose 5.6% to $2.81.
- Intra-Cellular Therapies, Inc. ITCI gained 5.6% to $8.61 after the company announced it has reached an agreement to submit additional non-clinical information in connection with the FDA's ongoing review of the Company's New Drug application for lumateperone.
- SUNDIAL GROWERS INC. SNDL rose 5.2% to $10.99 after surging 23.23% on Friday.
- Eyegate Pharmaceuticals Inc EYEG shares rose 4.8% to $0.22 after the company received FDA approval to initiate its follow-on pilot study for punctate epitheliopathies.
Check out these big penny stock gainers and losers
Losers
- GlycoMimetics, Inc. GLYC fell 60.2% to $3.6350. GlycoMimetics announced late Friday afternoon that Pfizer's Phase 3 clinical trial evaluating Rivipansel in sickle cell disease has not met its primary or key secondary endpoints. On Monday morning, a number of firms have also downgraded the stock.
- Cars.com Inc. CARS fell 33.3% to $12.04 after the company said it concluded a strategic review process and received no bids for the company. The company also reported worse-than-expected Q2 results and cut FY19 guidance.
- Genie Energy Ltd. GNE dropped 25.6% to $7.93 following Q2 results. Genie Energy posted Q2 loss of $0.29 per share on sales of $61.009 million.
- Daseke, Inc. DSKE dropped 24.8% to $2.6550 after the company reported worse-than-expected Q2 sales results. The company also cut its FY19 sales guidance below analyst estimates.
- Sohu.com Limited SOHU fell 23.7% to $9.33 following Q2 results.
- Diamond Offshore Drilling, Inc. DO dipped 16.6% to $6.18 after the company reported worse-than-expected Q2 EPS and sales results.
- Changyou.com Limited CYOU tumbled 14.7% to $6.42 after reporting Q2 results. Jefferies initiated coverage on Changyou.com with an Underperform rating and a $6.9 price target.
- Falcon Minerals Corporation FLMN fell 13.1% to $6.74 following downbeat Q2 results.
- Sogou Inc. SOGO dropped 13% to $3.36 following Q2 results.
- ATA Inc. ATAI shares declined 13% to $2.20.
- GDS Holdings Limited GDS fell 12.7% to $34.80.
- Fluidigm Corporation FLDM dipped 12.1% to $7.08.
- Regional Health Properties, Inc. RHE dropped 11.6% to $2.06.
- DYNATRACE HOLDINGS LLC DT dipped 11.5% to $23.08.
- Quotient Limited QTNT fell 11.2% to $10.00 following Q2 results.
- Unit Corporation UNT fell 10.8% to $5.18.
- Kemper Corporation KMPR dipped 10.4% to $77.36 despite reporting strong Q2 results.
- ON Semiconductor Corporation ON fell 10.3% to $17.92 after the company reported worse-than-expected Q2 sales results. The company also issued Q3 sales guidance below analyst estimates.
- Pluristem Therapeutics Inc. PSTI dropped 10% to $4.6650.
- Sea Limited SE fell 9.1% to $34.28 after rising 6.86% on Friday.
- Calithera Biosciences, Inc. CALA dropped 9% to $3.8150.
- Invitae Corporation NVTA fell 7.1% to $24.14.
- Amneal Pharmaceuticals, Inc. AMRX dropped 7% to $3.0250 after the company reported worse-than-expected Q2 EPS and sales results. The company also lowered FY19 EPS guidance.
- CNX Resources Corporation CNX shares fell 6.4% to $6.80.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralIntegrated Telecommunication ServicesMid-Day MoversTelecommunication ServicesTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in